Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-21 6:34 pm Purchase | 2024-05-07 | 13D | Trevi Therapeutics, Inc. TRVI | New Enterprise Associates 16, L.P. | 15,074,080 20.300% | 703,704 (+4.90%) | Filing History |
| 2024-04-25 7:39 pm Sale | 2024-03-31 | 13G | Trevi Therapeutics, Inc. TRVI | Rosalind Advisors, Inc. | 926,016 1.340% | -1,573,977 (-62.96%) | Filing History |
| 2024-02-14 8:47 pm Purchase | 2023-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Venrock Healthcare Capital Partners II, L.P. | 6,707,564 9.990% | 395,372 (+6.26%) | Filing History |
| 2024-02-14 3:48 pm Sale | 2023-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Fairmount Funds Management LLC | 0 0.000% | -6,018,465 (Position Closed) | Filing History |
| 2024-02-14 10:21 am Purchase | 2023-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | VIKING GLOBAL INVESTORS LP | 6,599,062 9.990% | 436,700 (+7.09%) | Filing History |
| 2024-02-12 06:06 am Unchanged | 2023-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Rubric Capital Management LP | 5,684,420 8.900% | 0 (Unchanged) | Filing History |
| 2023-02-15 1:16 pm Purchase | 2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Rosalind Advisors, Inc. | 2,499,993 4.200% | 314,329 (+14.38%) | Filing History |
| 2023-02-14 4:55 pm Purchase | 2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Venrock Healthcare Capital Partners II, L.P. | 6,312,192 9.990% | 2,643,858 (+72.07%) | Filing History |
| 2023-02-14 3:45 pm Purchase | 2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Fairmount Funds Management LLC | 6,018,465 9.900% | 2,258,955 (+60.09%) | Filing History |
| 2023-02-14 1:37 pm Purchase | 2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Armistice Capital, LLC | 3,147,200 4.990% | 446,401 (+16.53%) | Filing History |
| 2023-02-14 1:18 pm Purchase | 2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | VIKING GLOBAL INVESTORS LP | 6,162,362 9.990% | 177,628 (+2.97%) | Filing History |
| 2023-02-10 4:25 pm Sale | 2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | TPG GP A, LLC | 0 0.000% | -4,824,883 (Position Closed) | Filing History |
| 2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Rubric Capital Management LP | 5,684,420 9.490% | 5,684,420 (New Position) | Filing History |
| 2022-10-07 5:29 pm Purchase | 2022-09-27 | 13G | Trevi Therapeutics, Inc. TRVI | VIKING GLOBAL INVESTORS LP | 5,984,734 9.990% | 5,984,734 (New Position) | Filing History |
| 2022-10-07 2:51 pm Purchase | 2022-10-05 | 13G | Trevi Therapeutics, Inc. TRVI | Frazier Life Sciences Public Fund, L.P. | 6,663,590 11.400% | 2,847,131 (+74.60%) | Filing History |
| 2022-04-25 5:04 pm Purchase | 2022-04-11 | 13D | Trevi Therapeutics, Inc. TRVI | New Enterprise Associates 16, L.P. | 14,370,376 42.500% | 6,580,526 (+84.48%) | Filing History |
| 2022-04-21 4:05 pm Purchase | 2022-04-11 | 13G | Trevi Therapeutics, Inc. TRVI | Venrock Healthcare Capital Partners II, L.P. | 3,668,334 9.990% | 3,668,334 (New Position) | Filing History |
| 2022-04-21 10:00 am Purchase | 2022-04-11 | 13G | Trevi Therapeutics, Inc. TRVI | Fairmount Funds Management LLC | 3,759,510 9.900% | 3,759,510 (New Position) | Filing History |
| 2022-04-18 1:32 pm Purchase | 2022-04-11 | 13G | Trevi Therapeutics, Inc. TRVI | Frazier Life Sciences Public Fund, L.P. | 3,816,459 10.000% | 3,816,459 (New Position) | Filing History |
| 2022-04-08 10:41 am Purchase | 2022-03-30 | 13G | Trevi Therapeutics, Inc. TRVI | MAI Capital Management | 1,541,471 5.000% | 1,541,471 (New Position) | Filing History |